total attack rate (%) |
41.11 (40.12–42.22) |
6.50 (5.33–7.59) |
33.59 (32.38–34.67) |
clinical attack rate (%) |
25.13 (24.38–25.74) |
3.97 (3.25–4.60) |
20.36 (19.29–21.12) |
asymptomatic attack rate (%) |
16.00 (15.64–16.47) |
2.55 (2.12–2.99) |
13.20 (12.19–13.69) |
case fatality rate (%) |
2.96 (2.74–3.12) |
1.40 (1.15–1.73) |
2.84 (2.2–3.04) |
infection fatality rate (%) |
1.80 (1.67–1.90) |
0.84 (0.70–1.04) |
1.72 (1.1–1.84) |
number of shutdown days (from 8 Sep 2020 to 7 Jan 2022) |
0 (0–0) |
195 (168–213) |
255 (213–255) |
total cases (clinical and asymptomatic) per 100 000 |
41 145 (40 157–42 256) |
6503 (5336–7595) |
33 625 (32 309–34 703) |
total clinical cases per 100 000 |
25 151 (24 405–25 766) |
3973 (3249–4607) |
20 384 (19 505–21 137) |
total asymptomatic cases per 100 000 |
16 015 (15 659–16 490) |
2556 (2124–2988) |
13 217 (12 804–13 707) |
total hospitalized cases (acute and ICU) per 100 000 |
2618 (2483–2763) |
408 (324–464) |
2091 (1985–2242) |
total acute hospitalized cases per 100 000 |
1957 (1859–2073) |
292 (239–351) |
1568 (1477–1671) |
total cases admitted into the ICU per 100 000 |
664 (615–716) |
101 (76–132) |
532 (479–574) |
total deaths per 100 000 |
740 (670–790) |
54 (45–71) |
577 (542–623) |
proportion of infections acquired at school (%) |
10.23 (9.92–10.68) |
7.13 (6.13–8.22) |
11.66 (11.10–11.98) |
proportion of infections acquired at work (%) |
12.26 (11.83–12.66) |
10.98 (9.84–11.76) |
7.21 (6.75–7.78) |
proportion of infections acquired in mixed-age venues (%) |
21.96 (21.50–22.23) |
21.45 (19.69–22.76) |
23.94 (23.57–24.48) |
proportion of infections acquired in the household (%) |
55.56 (55.29–56.02) |
60.53 (59.63–61.40) |
57.19 (56.87–57.43) |